Several studies have demonstrated high expression of PRMT5 in various tumor types including lung cancer, breast cancer, hematologic malignancies, glioblastoma, and colorectal cancer, and these studies demonstrate an important role for PRMT5 in tumorigenesis (7–11). Here, PRMT5 is linked to lung carcinoma.